ArticleJournal of cancer research and clinical oncology2024

Does the time interval from neoadjuvant camrelizumab combined with chemotherapy to surgery affect outcomes for locally advanced esophageal squamous cell carcinoma?

Jiacong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.